miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 11367-11373

  Zhai, Ronglin ^a   Kan, Xuefeng ^a   Wang, Bo ^a   Du, Hansong ^a   Long, Yueping ^a   Wu, Heshui ^a   Tao, Kaixiong ^a   Wang, Guobin ^a   Bao, Lihong ^a   Li, Fen ^a   Zhang, Wanli ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CD151; Gastric cancer; Growth; Metastasis; miR 152

Indexed keywords

CD151 ANTIGEN; CD151 PROTEIN, HUMAN; MESSENGER RNA; MICRORNA; MIRN152 MICRORNA, HUMAN;

APOPTOSIS; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL CULTURE; TUMOR INVASION; WESTERN BLOTTING;

ANTIGENS, CD151; APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84927786619     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2471-2     Document Type: Article

References (22)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. Wang YY, Ye ZY, Zhao ZS, Tao HQ, Li SG. Systems biology approach to identification of biomarkers for metastatic progression in gastric cancer. J Cancer Res Clin Oncol. 2010;136:135–41.
3. Otani K, Li X, Arakawa T, Chan FK, Yu J. Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer. Expert Rev Mol Diagn. 2013;13:445–55.
4. Zoller M. Gastrointestinal tumors: metastasis and tetraspanins. Z Gastroenterol. 2006;44:573–86.
5. Pols MS, Klumperman J. Trafficking and function of the tetraspanin cd63. Exp Cell Res. 2009;315:1584–92.
6. Sadej R, Romanska H, Kavanagh D, Baldwin G, Takahashi T, Kalia N, et al. Tetraspanin cd151 regulates transforming growth factor beta signaling: implication in tumor metastasis. Cancer Res. 2010;70:6059–70.
7. Kwon MJ, Seo J, Kim YJ, Choi JY, Kim TE, Lee DH, et al. Prognostic significance of cd151 overexpression in non-small cell lung cancer. Lung Cancer. 2013;81:109–16.
8. Yang YM, Zhang ZW, Liu QM, Sun YF, Yu JR, Xu WX. Overexpression of cd151 predicts prognosis in patients with resected gastric cancer. PLoS One. 2013;8:e58990.
9. Zhang N, Wei X, Xu L. Mir-150 promotes the proliferation of lung cancer cells by targeting p53. FEBS Lett. 2013;587:2346.
10. Ayaz L, Gorur A, Yaroglu HY, Ozcan C, Tamer L. Differential expression of micrornas in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol. 2013;139:1499.
11. Wach S, Nolte E, Theil A, Stohr C, Rau TT, Hartmann A, et al. Microrna profiles classify papillary renal cell carcinoma subtypes. Br J Cancer. 2013;109:714.
12. Chen J, Yao D, Li Y, Chen H, He C, Ding N, et al. Serum microrna expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Int J Mol Med. 2013;32:557.
13. Chang L, Guo F, Wang Y, Lv Y, Huo B, Wang L, et al. Microrna-200c regulates the sensitivity of chemotherapy of gastric cancer sgc7901/ddp cells by directly targeting rhoe. Pathol Oncol Res. 2013;20:93.
14. Jiang B, Li Z, Zhang W, Wang H, Zhi X, Feng J, et al. Mir-874 inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer. J Gastroenterol. 2013;49:1011.
15. Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C, et al. Altered expression of mir-148a and mir-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg. 2010;14:1170–9.
16. Huang J, Wang Y, Guo Y, Sun S. Down-regulated microrna-152 induces aberrant DNA methylation in hepatitis b virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology. 2010;52:60–70.
17. Zhu C, Li J, Ding Q, Cheng G, Zhou H, Tao L, et al. Mir-152 controls migration and invasive potential by targeting TGFalpha in prostate cancer cell lines. Prostate. 2013;73:1082–9.
18. Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu G, et al. Mir-152 and mir-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting dnmt1 directly: a novel epigenetic therapy independent of decitabine. Oncogene. 2013;33:378.
19. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. 2005;6:801–11.
20. Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji Y, et al. Microrna-124 suppresses breast cancer cell growth and motility by targeting cd151. Cell Physiol Biochem. 2013;31:823–32.
21. Fei Y, Wang J, Liu W, Zuo H, Qin J, Wang D, et al. Cd151 promotes cancer cell metastasis via integrins alpha3beta1 and alpha6beta1 in vitro. Mol Med Rep. 2012;6:1226–30.
22. Rubinstein E. The complexity of tetraspanins. Biochem Soc Trans. 2011;39:501–5.